**Core Concept**
ALL-L3 refers to Acute Lymphoblastic Leukemia with lymphoblasts in the L3 (Burkitt) stage. This condition is characterized by a specific type of lymphoblastic leukemia that involves a translocation involving the MYC gene on chromosome 8 and one of the immunoglobulin genes on chromosomes 14, 2, or 22.

**Why the Correct Answer is Right**
The L3 stage of ALL is a distinct clinical and pathological entity that is often associated with a high proliferation rate and a poor prognosis. The Burkitt lymphoma/leukemia cells are large, with prominent nucleoli and a high mitotic rate. This stage is often seen in children, but can also occur in adults. The MYC gene translocation is a hallmark of this disease, leading to the overexpression of the MYC protein and uncontrolled cell proliferation.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the morphology and pathogenesis of ALL-L3. Burkitt lymphoma/leukemia cells are distinct from the more common lymphoblasts seen in other stages of ALL.
**Option B:** This option is incorrect because it does not specify the characteristic translocation involving the MYC gene, which is a key feature of ALL-L3.
**Option C:** This option is incorrect because it does not accurately describe the clinical and pathological features of ALL-L3.

**Clinical Pearl / High-Yield Fact**
The L3 stage of ALL is often associated with a high risk of central nervous system (CNS) involvement and requires aggressive treatment, including CNS prophylaxis.

**Correct Answer:** C.